GFAP and Parkinson disease: This study revealed that norepinephrine neuronal damage can lower the nociception threshold of 6‐OHDA‐induced PD rats, and the rats showed an increased proportion of GFAP positive cells in the prefrontal lobe and cingulate gyrus.